Hypogonadotrophic hypogonadism, delayed puberty and risk for neurodevelopmental disorders

• Published in: Journal of neuroendocrinology Vol. 31; no. 11; pp. e12803 - n/a
• Main Authors: Ohlsson Gotby, Vide, Söder, Olle, Frisén, Louise, Serlachius, Eva, Bölte, Sven, Almqvist, Catarina, Larsson, Henrik, Lichtenstein, Paul, Tammimies, Kristiina
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.11.2019
• Subjects: Attention deficit hyperactivity disorder; Autism; autism spectrum disorder; Hypogonadism; Infertility; Intellectual disabilities; intellectual disability; International Classification of Diseases; Klinefelter's syndrome; Medicin och hälsovetenskap; Neurodevelopmental disorders; Puberty; Sensitivity analysis; sex hormones; International Classification of Diseases; attention deficit hyperactivity disorder; sex hormones; autism spectrum disorder; intellectual disability
• ISSN: 0953-8194; 1365-2826; 1365-2826
• DOI: 10.1111/jne.12803

Hypogonadotrophic hypogonadism (HH) is a rare disorder that manifests absent puberty and infertility. Genetic syndromes with hypogonadism, such as Klinefelter syndrome, are associated with an increased risk of neurodevelopmental disorders (NDDs). However, it is not clear whether patients with HH or transient delayed puberty in general, have an increased risk of NDDs. We performed a register‐based study on a national cohort of 264 patients with HH and 7447 patients diagnosed with delayed puberty that was matched with 2640 and 74 470 controls, respectively. The outcome was defined as having any of the following NDD diagnoses: (i) autism spectrum disorder (ASD); (ii) attention deficit hyperactivity disorder (ADHD); or (iii) intellectual disability (ID). Additional sensitivity analyses were performed to control for different parental and birth variables, as well as diagnosed malformation syndromes and chromosomal anomalies (ie, Down’s and Turner syndromes). Patients with HH had increased risk for being diagnosed with ASD (odds ratio [OR] = 5.7; 95% confidence interval [CI] = 2.6‐12.6), ADHD (OR = 3.0; 95% CI = 1.8‐5.1) and ID (OR = 18.0; 95% CI = 8.9‐36.3) compared to controls. Patients with delayed puberty also had a significantly increased risk of being diagnosed with an NDD. These associations remained significant after adjustments. This is the first study to demonstrate a significant association between HH, delayed puberty and NDDs in a population‐based cohort. Clinicians should be aware of the overlap between these disorders. Further studies should explore the mechanisms behind these associations.